FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

Oncternal Therapeutics, Inc. — Operating Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/66757c5f-bb46-4760-86e2-e06130daaf6f/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2023$-41.7M2023-01-01 – 2023-12-31evidence 0000950170-24-027984
FY 2022$-44.9M2022-01-01 – 2022-12-31evidence 0000950170-23-007062
FY 2021$-31.4M2021-01-01 – 2021-12-31evidence 0001564590-22-009702
FY 2020$-17.5M2020-01-01 – 2020-12-31evidence 0001564590-21-012588
FY 2019$-33.1M2019-01-01 – 2019-12-31evidence 0001564590-20-011213
FY 2018$-7.6M2018-01-01 – 2018-12-31evidence 0001564590-20-011213
FY 2017$-30.7M2017-01-01 – 2017-12-31evidence 0001047469-18-001564
FY 2016$-25.9M2016-01-01 – 2016-12-31evidence 0001047469-17-001982
FY 2015$-21.8M2015-01-01 – 2015-12-31evidence 0001047469-16-011178
FY 2014$-30.3M2014-01-01 – 2014-12-31evidence 0001047469-15-002283
FY 2013$-43.6M2013-01-01 – 2013-12-31evidence 0001104659-14-018791
FY 2012$-49.7M2012-01-01 – 2012-12-31evidence 0001047469-13-002200
FY 2011$-35.9M2011-01-01 – 2011-12-31evidence 0001047469-13-002200
FY 2010$15.1M2010-01-01 – 2010-12-31evidence 0001047469-13-002200
FY 2009$-46.7M2009-01-01 – 2009-12-31evidence 0001193125-12-093770
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Oncternal Therapeutics, Inc. — all facts · Revenue · Net Income